Table 6.
Rejection of DF, E2, and EE2 by membrane filtration
| Compound | Membrane type | Rejection (%)a | Reference |
|---|---|---|---|
| Diclofenac | NF | 100 | Radjenović et al. (2009) |
| RO | 100 | Radjenović et al. (2009) | |
| NF | 60 | Röhricht et al. (2009) | |
| NF | 65 | Röhricht et al. (2010) | |
| MBR/RO | 95 | Sahar et al. (2011) | |
| E2 | RO | 83 | Kimura et al. (2007a, b) |
| NF/RO | 90 | Nghiem et al. (2005) | |
| NF | >99 | Weber et al. (2004) | |
| NF | >95 | Yoon et al. (2007) | |
| RO/NF | High | Drewes et al. (2005) | |
| NF | 77 | Bodzek and Dudziak (2006) | |
| DCMD | ≥99.5 | Cartinella et al. (2006) | |
| NF | 100 | Koyuncu et al. (2008) | |
| NF/RF | 100 | Alturki et al. (2010) | |
| NF | 100 | McCallum et al. (2008) | |
| EE2 | NF | >99 | Weber et al. (2004) |
| NF | 90 | Dudziak and Bodzek (2009) | |
| NF | 60 | Yoon et al. (2007) | |
| NF/RO | 99 | Alturki et al. (2010) |
NF nanofiltration, RO reverse osmosis, MBR membrane bioreactor, DCMD direct contact membrane distillation
aUnder optimal conditions